ATB |
miR-590-5p |
lncRNA represses miRNA expression |
NF-90 |
ATB
upregulated in lung tissue and promote tumorigenesis and cell
proliferation, migration, and Invasion |
Lung Squamous Carcinoma Cell |
[63] |
CHRF |
miR-489 |
lncRNA represses miRNA expression |
Myd88 |
lncRNA CHRF
modulate miR-489/Myd88 axis to inhibit cell proliferation, Migration,
Invasion, Apoptosis |
NSCLC |
[64] |
CCAT1 |
miR-218 |
lncRNA represses miRNA expression |
BMI-1 |
lncRNA
CCAT1 downregulate miR-218 then inhibit BMI-1 to promotes anti-apoptosis
and cell proliferation |
NSCLC |
[65] |
DLEU2 |
miR-30c-5p |
ceRNA |
SOX9 |
lncRNA DLEU2 downregulate miR-30c-5p
and promote SOX9, contribute to tumorigenesis and metastasis, shorter
overall survival |
NSCLC |
[66] |
MBNL1-AS1 |
miR-301b-3p |
ceRNA |
TGFBR2 |
lncRNA MBNL1-AS1 positively
regulated TGFBR2 by competitively binding to miR-301b-3p, promote
proliferation, migration, invasion, drug resistance, and sphere
formation of cancer stem cell |
NSCLC |
[67] |
LINC00240 |
miR-7-5p |
ceRNA |
EGFR |
LncRNA LINC00240 suppresses
invasion and migration by sponging miR-7-5p and induced the
overexpression of EGFR |
NSCLC |
[68] |
XIST |
miR-335 |
ceRNA |
SOD2 |
XIST facilitated NSCLC progression by
miR-335/SOD2/ROS signal pathway inhibited pyroptotic cell death |
NSCLC |
[69] |
LINC00662 |
miR-320d |
ceRNA |
E2F1 |
LINC00662 promotes cancer progress
by miR-320d/E2F1 axis |
NSCLC |
[70] |
MEG3 |
miR-7-5p |
ceRNA |
BRCA1 |
MEG3 increases apoptosis of lung
cancer cells by competitive binding to microRNA-7-5p reducing the
BRCA1 expression. |
NSCLC |
[71] |
LINC01436 |
miR-30a-3p |
ceRNA |
EPAS1 |
LINC01436 promotes lung cancer
cell growth, migration, and invasion |
NSCLC |
[72] |
CASC2 |
miR-21 |
lncRNA represses miRNA expression |
p53 |
CASC2
suppresses cell proliferation and enhances apoptosis. |
LUAD |
[73] |
H19 |
miR-107 |
ceRNA |
NF1 |
H19 increases the proliferative and
migratory abilities of cancer cells |
NSCLC |
[74] |
H19 |
miR-196b |
ceRNA |
LIN28B |
H19 accelerates cell proliferation in
lung cancer |
lung cancer |
[75] |
LINC00857 |
miR-1179 |
ceRNA |
SPAG5 |
LINC00857 promoted cell growth
and glycolysis and repressed apoptosis |
LUAD |
[76] |
NNT-AS1 |
miR-129-5p |
ceRNA |
- |
NNT-AS1 increases lung cancer cells
proliferation and invasion ability |
NSCLC |
[77] |
SNHG16 |
miR-520 |
ceRNA |
VEGF |
SNHG16 drives proliferation,
migration, and invasion of lung cancer cell |
NSCLC |
[78] |
UCA1 |
miR-383 |
ceRNA |
VEGFA |
UCA1 increases cell proliferation,
migration and invasion |
LUAD |
[79] |
PGM5P4-AS1 |
miR-1275 |
ceRNA |
LZTS3 |
PGM5P4-AS1 inhibiteS lung cancer
cell proliferation, migration, and invasion activities |
lung cancer |
[80] |
1308 |
miR-124 |
ceRNA |
ADAM15 |
facilitates NSCLC cell proliferation
and invasion |
NSCLC |
[81] |
DLGAP1-AS1 |
miR-193a-5p |
ceRNA |
DTL |
exhibits oncogenic properties |
NSCLC |
[82] |
GAS5 |
miR-21 |
ceRNA |
PTEN |
increases the radiosensitivity and
promotes the IR‑induced cell apoptosis |
NSCLC |
[83] |
PVT1-5 |
miR-126 |
ceRNA |
SLC7A5 |
promotes cell proliferation |
lung
cancer |
[84] |
SNHG3 |
miR-1343-3p |
ceRNA |
NFIX |
promotes the development of
non‑small cell lung cancer |
NSCLC |
[85] |
SNHG4 |
miR-let-7e |
ceRNA |
KDM3A |
promotes cell viability, colony
formation, invasion, migration, and cycle progression while reducing
apoptosis |
NSCLC |
[86] |
SNHG1 |
miR-145-5p |
ceRNA |
MTDH |
promotes non-small cell lung cancer
progression |
NSCLC |
[87] |
LOC146880 |
miR-539-5p |
miRNA negatively regulates lncRNA |
ENO1 |
declines phosphorylation of an oncogene, ENO1, and then reduces cell
proliferation and tumor progression |
NSCLC |
[88] |